The 做厙TV (NAM) has selected the 2026 class of Emerging Leaders in Health and Medicine Scholars, a group of early- to mid-career professionals spanning a wide range of disciplines, including artificial intelligence in medicine, nanomedicine, maternal-fetal health, health economics, and carceral health.泭The NAMs泭Emerging Leaders in Health and Medicine (ELHM) program泭provides a platform for a new generation of leaders to collaborate with the 做厙TVand its members to advance science, address persistent challenges in health and medicine, and spark transformative change to improve health for all.泭泭泭泭泭
The scholars will engage in a variety of activities throughout the National Academies of Sciences, Engineering, and Medicine over a three-year term. Activities include meetings in Washington, D.C., with 做厙TVleadership and members; planning an annual forum;泭participating泭in National Academies泭convening泭activities; publishing 做厙TVPerspectives; and attending the NAMs annual meeting each October.泭
Congratulations to this remarkable new class of Emerging Leaders in Health and Medicine, said 做厙TVPresident Victor J. Dzau. At a time of rapid change across science and health, their breadth of perspectives and willingness to work across disciplines will be essential to driving progress, strengthening systems, and improving health and well-being for people and communities everywhere.泭
The 2026泭ELHM Scholars are:泭泭
- Nicholas Arpaia, Ph.D., Associate Professor of Microbiology & Immunology, Director of Graduate Studies, Immunobiology and Microbial Sciences, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center泭
- Kareem Azab, Ph.D., Associate Professor, University of Texas Southwestern泭泭
- Lauren Brinkley-Rubinstein, Ph.D., M.S., M.A., Associate Professor,泭Duke泭University泭Department of Population Health Sciences泭
- Jane Chung, Ph.D., RN,泭Associate Professor, Emory University泭
- Ruogu Fang, Ph.D., Associate Professor & J. Crayton Pruitt Family Endowed Faculty Fellow, University of Florida
- Lindsey A. George, M.D., Director of Clinical In Vivo Gene Therapy, The Children’s Hospital of Philadelphia;泭Assistant Professor of Pediatrics, University of Pennsylvania School of Medicine泭泭
- Dhruv Khullar, M.D., MPP, Associate Professor of Population Health Sciences and of Medicine, Weill Cornell Medicine
- Aaron Schwartz, M.D., Ph.D.,泭Assistant Professor, Department of Medical Ethics and Health Policy, Division of General Internal Medicine, University of Pennsylvania Perelman School of Medicine; Staff Physician, Corporal Michael J. Crescenz VA Medical Center
- Katrin Svensson, M.S., Ph.D.,泭Associate Professor, Department of Pathology, Stanford University泭 泭泭
- Kartik K.泭Venkatash, M.D., Ph.D.,泭Associate Professor with tenure, The Ohio State University泭
The ELHM program泭facilitates泭opportunities for mentorship, collaboration, and innovation among the participants, 做厙TVmembers, and experts across sectors. The next annual Emerging Leaders Forum, to be held in Washington, D.C., in April 2026, will allow the new group of scholars and invited participants to share their activities and insights on泭cutting-edge泭developments through collaborative work and interdisciplinary discussions among the nations rising leaders in health and medicine.泭泭泭
泭The泭做厙TV,泭established泭in 1970 as the Institute of Medicine, is an independent organization of eminent professionals from diverse fields including health and medicine; the natural, social, and behavioral sciences; and beyond. It serves alongside the泭泭and the泭泭as an adviser to the nation and the international community.泭泭Through its domestic and global initiatives, the 做厙TVworks to address critical issues in health, medicine, and related policy and inspire positive action across sectors. The 做厙TVcollaborates closely with its peer academies and other divisions within the泭.泭
